nach oben

Erschienen in:

01.05.2014 | Original Article

Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study

verfasst von: Marilyn M. Schapira, Elizabeth R. Mackenzie, Regina Lam, David Casarett, Christina M. Seluzicki, Frances K. Barg, Jun J. Mao

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Acupuncture is a complementary and alternative medicine (CAM) modality that shows promise as a component of supportive breast cancer care. Lack of robust recruitment for clinical trial entry has limited the evidence base for acupuncture as a treatment modality among breast cancer survivors. The objective of this study is to identify key decision-making factors among breast cancer survivors considering entry into an acupuncture clinical trial for treatment of symptoms.

Methods

Semistructured interviews were conducted among African–American (n = 12) and Caucasian (n = 13) breast cancer survivors. Verbatim transcripts were made and analyzed by two or more independent coders using NVivo software. Major recurring themes were identified and a theoretical framework developed.

Results

Six themes emerged reflecting key attributes of the decision to enter a clinical trial: (1) symptom appraisal, (2) practical barriers (e.g., distance and travel), (3) beliefs about the interventions (e.g., fear of needles and dislike of medications), (4) comfort with elements of clinical trial design (e.g., randomization, the nature of the control intervention, and blinding), (5) trust, and (6) altruism. African–American and Caucasian women weighed similar attributes but differed in the information sources sought regarding clinical trial entry and in concerns regarding the use of a placebo in a clinical trial.

Conclusions

Our findings contribute to the development of a theoretical model of decision making for breast cancer survivors considering participation in a CAM clinical trial. Insights regarding the decision making process can inform interventions to support informed decision making and robust recruitment to CAM trials among cancer survivors.

Mao JJ, Palmer C, Healy K, Desair K, Amsterdam J (2010) Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. DOI: 10.1007/s11764-010-0153-7.

Morris KT, Johnson N, Homer L, Walts D (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179(5):407–411PubMedCrossRef

Boon HS, Olatunde F, Zick SM. (2007) Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005. BMC Wom Health 7(4).

Wyatt G et al (2010) Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res 59(1):58–66PubMedCrossRef

Matthews AK, Sellerggren SA, Huo D, List M, Fleming G (2007) Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13(5):555–562PubMedCrossRef

MacPhearson H, Hammerschlag R (2012) Acupuncture and the emerging evidence base: contrived controversy and rational debate. J Acupunct Meridian Stud 5(4):141–147CrossRef

Ernst E, Pittler MH, Wider B, Boddy K (2007) Complementary/alternative medicine for supportive cancer care: development of the evidence base. Support Care Cancer 15:565–568PubMedCrossRef

Capodice JL (2010) Acupuncture in the oncology setting: clinical trial update. Curr Treat Options Oncol 11(3–4):87–94PubMedCrossRef

Brauer JA, Sehamy A, Metz JM, Mao JJ (2010) Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of website. J Altern Complement Med 16(2):183–186PubMedCentralPubMedCrossRef

10.

Lara PN Jr, Paterniti DA, Chiechi C et al (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23:9282–9289PubMedCrossRef

11.

Hondras MA, Long CR, Haan AG, Spencer LB, Meeker WC (2008) Recruitment and enrollment for the simultaneous conduct of 2 randomized controlled trials for patients with subacute and chronic low back pain at a CAM research center. J Altern Complement Med 14(8):983–992PubMedCentralPubMedCrossRef

12.

Pastore LM, Dalal P (2009) Recruitment strategies for an acupuncture randomized clinical trial of reproductive age women. Complement Ther Med 17(4):229–235PubMedCentralPubMedCrossRef

13.

Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, Parlour L, Farewell V, Fallowfield L (2010) The attitudes of 1066 patients with cancer towards participation in randomized clinical trials. Br J Cancer 103(12):1801–1807PubMedCentralPubMedCrossRef

14.

Watson JM, Torgerson DJ (2006) Increasing recruitment to randomized trials: a review randomized controlled trials. BMC Med Res Methodol 6:34PubMedCentralPubMedCrossRef

15.

Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting under representative populations to cancer clinical trials: a systematic review. Cancer 112:228–242PubMedCrossRef

16.

Schmotzer GL (2012) Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis 22(2):226–230PubMed

17.

Paskett ED, Katz ML, DeGraffinereid CR, Tatum CM (2003) Participation in cancer trials: recruitment of underserved populations. Clin Adv Hematol Oncol 1(10):607–613PubMed

18.

Bruner DW, Jones M, Buchanan D, Russo J (2006) Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol 24(14):2209–2215PubMedCrossRef

19.

Su HI, Sammel MD, Springer E, Freeman EW, Demichele A, Mao JJ (2010) Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat 124(1):205–211

20.

Mao JJ, Leed R, Bowman MA et al (2012) Acupuncture for hot flashes: decision making by breast cancer survivors. J Am Board Fam Med 25:323–332PubMedCentralPubMedCrossRef

21.

Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in postmenopausal women treated for breast carcinoma; prevalence, severity, correlates, management, and relation to quality of life. Cancer 82(9):1682–1691PubMedCrossRef

22.

Carpenter JS, Johnson D, Wagner L, Andrykowski M (2002) Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 29(3):E16–E25PubMedCrossRef

23.

Ellis PM (2000) Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol 11:939–945PubMedCrossRef

24.

Osann K, Wenzel L, Dogan A, Hsieh S, Chase DM, Sappington S, Monk BJ, Nelson E (2011) Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial. Gynecol Oncol 121(3):558–564PubMedCrossRef

25.

Schneider J, Vuckovic N, DeBar L (2003) Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders. J Altern Complement Med 9(3):389–401PubMedCrossRef

26.

Madsen SM, Holm S, Riis P (2007) Attitudes toward clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. J Med Ethics 33(4):234–240PubMedCentralPubMedCrossRef

27.

Bishop FL, Jacobson EE, Shwa JR, Kaptchuk TJ (2012) Scientific tools, fake treatments, or triggers for psychological healing: how clinical trial participants conceptualise placebos. Soc Sci Med 74(5):767–774PubMedCentralPubMedCrossRef

28.

Prady SL, Burch J, Crouch S, MacPherson H (2013) Insufficient evidence to determine the impact of patient preferences on clinical outcomes in acupuncture trials: a systematic review. J Clin Epidemiol 66:308–318PubMedCrossRef

29.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG (2005) Lay public’s understanding of equipoise and randomisation in randomized controlled trials. Health Technol Assess 9(8):1–192, iii–iv.

30.

Gotay CC, Wilson ME (1998) Social support and cancer screening in African American, Hispanic, and Native American Women. Cancer Pract 6(1):31–37PubMedCrossRef

31.

Henderson PD, Gord SV, Davis L, Condon EH (2003) African American women coping with breast cancer: a qualitative analysis. Oncol Nurs Forum 30(4):641–647PubMedCrossRef

32.

Gorelick PB, Harris Y, Burnett B, Bonecutter FJ (1998) The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. J Natl Med Assoc 90:141–145PubMedCentralPubMed

33.

Gamble VN (1997) Under the shadow of Tuskegee: African Americans and health care. Am J Public Health 87:1773–1778PubMedCentralPubMedCrossRef

34.

Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999) Attitudes and beliefs of African American towards participation in medical research. J Gen Intern Med 14:537–546PubMedCentralPubMedCrossRef

35.

Corbie-Smith G, Thomas SB, St George DM (2002) Distrust, race, and research. Arch Intern Med 162(21):2458–2463PubMedCrossRef

Titel: Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study
verfasst von: Marilyn M. Schapira
Elizabeth R. Mackenzie
Regina Lam
David Casarett
Christina M. Seluzicki
Frances K. Barg
Jun J. Mao
Publikationsdatum: 01.05.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 5/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-013-2073-3

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study